foxo4-dri peptide senolytic human trial UK | Research Buy FOXO4-DRI UK | ≥98%
Buy FOXO4 DRI UK 98% Purity Next Day Dispatch Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC Buy FOXO4 DRI Peptide Vial UK PharmaLabGlobal The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




